Thymogen

Thymogen is a thymic-derived short peptide immunomodulator that promotes T-cell activity, immune rebalancing, and resistance to infection. It is widely used in Eastern European protocols to support immune function, particularly in cases of immunodeficiency, chronic infection, or age-related immune decline.

• Stimulates thymus-derived lymphocyte differentiation
• Enhances T-cell receptor expression and immunologic memory
• Regulates cytokine production and immune signaling cascades

• unit: mcg

  low dose: 50

  frequency: Once daily

  high dose: 150

  standard dose: 100

  administration route: Subcutaneous (SQ)

• Administer daily for 10–14 days. Repeat cycle every 3–6 months or as needed based on immune status.

common: ["Redness or soreness at injection site","Mild fatigue"]

warnings: ["Not recommended for use in autoimmune disorders due to potential for immune overstimulation"]

long term: ["May lead to immune exhaustion or imbalance with extended use; monitor in chronic administration"]

sequence: H-Ala-Lys-Glu-Asp-OH

half life: Approximately 60 minutes

degradation: Broken down by proteases in plasma and liver

molecular weight: 453.53

molecular formula: C22H33N6O5

tissue specificity: Preferentially targets thymus, spleen, and peripheral immune cells

• Thymogen in the treatment of type-1 diabetes mellitus.clinicalPMID 9026934 ↗
• The efficacy of using thymogen in an experimental infection caused by Yersinia enterocolitica.preclinicalPMID 7660690 ↗